Our Products

Our products support the health of patients in the areas of maternal and women's health, anemia management and cancer supportive care. More

Research & Development

We recognize the immense value of clinical research and are committed to investing in it to expand the body of knowledge in our therapeutic areas and advance potential future health innovations for patients. More

AMAG Corporate Principles

Our company values provide an important framework for who we are and how we operate. AMAG is also committed to a set of corporate principles that guide how we pursue our business goals and deliver on our promise to patients and their families. More

News

AMAG Pharmaceuticals to Present at Upcoming Investor Conferences

AMAG Pharmaceuticals to Present at Upcoming Investor Conferences

WALTHAM, Mass., November 13, 2019 – AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that company management will participate in the following More

Makena® (hydroxyprogesterone caproate injection) Approval and Product Label...

Makena® (hydroxyprogesterone caproate injection) Approval and Product Label Remain Unchanged

The U.S. Food and Drug Administration’s (FDA) Bone, Reproductive and Urologic Drugs Advisory Committee's recommendation on October 29, 2019 has led to some More

Working at AMAG

"I get to wear a lot of different hats in an industry that provides very fast-paced and interesting work along with the opportunity to solve the puzzle of treatments for difficult diseases."

David Knauss
Senior Manager, Regulatory Affairs & Medical Writing